Discuss your management plan for this patient, including pharmacologic therapies, tests,
patient education, referrals, and follow-ups.
Several factors should affect the decision to provide presumptive therapy for cervi
...
Discuss your management plan for this patient, including pharmacologic therapies, tests,
patient education, referrals, and follow-ups.
Several factors should affect the decision to provide presumptive therapy for cervicitis or
to await the results of diagnostic tests. Treatment with antibiotics for C. trachomatis should be provided for those women at increased risk for this common STD with a dose of Ceftriaxone 250
mg IM and Doxycycline 100 mg orally twice a day for 7 days can be used as an alternative in
women who are not pregnant or breast feeding (Ebrahimy et al., 2015).
Patients must be educated that cervicitis is a preventable, sexually transmitted infection
(STI) and that the most effective way to prevent the transmission of the infective agents is to
avoid sexual intercourse without protection or infected partners. Partners should be notified and
examined if chlamydia, gonorrhea, or trichomoniasis. Partners should then be treated for the
STDs for which the index patient received treatment. Education on avoiding reinfection, patients
and their sex partners should abstain from sexual intercourse until therapy is completed (Öztürk
& Ulubay, 2016).
Follow-up should be conducted as recommended for the infections for which a woman is
treated. If symptoms persist, women should be instructed to return for re-evaluation because
women with documented chlamydial or gonococcal infections have a high rate of reinfection
within 6 months after treatment. Therefore, repeat testing of all women with chlamydia or
gonorrhea is recommended 3-6 months after treatment, regardless of whether their sex partners
were treated (Ebrahimy et al., 2015)
[Show More]